NORTHERN TRUST CORP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$5,639,780
-19.9%
1,034,822
-1.4%
0.00%0.0%
Q2 2023$7,039,173
-22.8%
1,049,057
+1.6%
0.00%
-50.0%
Q1 2023$9,118,794
+19.9%
1,032,706
+3.7%
0.00%0.0%
Q4 2022$7,604,924
-8.4%
995,409
-14.6%
0.00%0.0%
Q3 2022$8,301,000
+1.4%
1,165,834
+15.3%
0.00%0.0%
Q2 2022$8,183,000
+27.0%
1,011,562
+117.9%
0.00%
+100.0%
Q1 2022$6,443,000
-50.8%
464,258
-0.5%
0.00%
-50.0%
Q4 2021$13,087,000
-19.5%
466,407
-2.5%
0.00%
-33.3%
Q3 2021$16,254,000
-14.1%
478,220
+3.3%
0.00%0.0%
Q2 2021$18,921,000
+12.0%
463,066
+10.4%
0.00%0.0%
Q1 2021$16,888,000
-30.3%
419,470
+2.3%
0.00%
-40.0%
Q4 2020$24,240,000
+21.8%
409,936
+0.2%
0.01%
+25.0%
Q3 2020$19,902,000
+14.3%
409,229
+13.7%
0.00%0.0%
Q2 2020$17,406,000
+67.3%
359,766
-3.9%
0.00%
+33.3%
Q1 2020$10,404,000
+207.7%
374,551
+231.5%
0.00%
+200.0%
Q4 2019$3,381,000
-3.8%
112,993
-0.6%
0.00%0.0%
Q3 2019$3,513,000113,6940.00%
Q2 2019$000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2023
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders